Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy
NCT06396780 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 233
Last updated 2024-07-22
Summary
The aim of this study is to describe the current status of treatment adherence in children with Helicobacter pylori infection, understand the medication literacy, medication beliefs of the children, knowledge of H. pylori among caregivers, medication beliefs, medication support, and explore the influencing factors of medication adherence.
Conditions
- Helicobacter Pylori Infection
- Children, Only
Sponsors & Collaborators
-
Wei XIA, PhD
lead OTHER
Principal Investigators
-
Wei Xia, PhD · Sun Yat-sen University
Eligibility
- Min Age
- 8 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-30
- Primary Completion
- 2025-02-28
- Completion
- 2025-03-31
Countries
- China
Study Locations
More Related Trials
-
A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children
NCT02302170 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
NCT02934048 ·Status: UNKNOWN ·Phase: PHASE4
-
Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori
NCT02761005 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Study to Diagnose Helicobacter Pylori in the Paediatric Population Using Non-invasive Fecal Analysis
NCT07083804 ·Status: RECRUITING
-
Effect of H.Pylori Infection on Growth Parameters
NCT06938035 ·Status: NOT_YET_RECRUITING
-
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
NCT05620602 ·Status: UNKNOWN
-
A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
NCT02689583 ·Status: UNKNOWN ·Phase: NA
-
Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
NCT03556254 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori(SHARE2302)
NCT05997433 ·Status: RECRUITING ·Phase: NA
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
NCT03571230 ·Status: UNKNOWN ·Phase: PHASE4
-
A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
NCT02923856 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
NCT05718609 ·Status: UNKNOWN ·Phase: PHASE4
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
NCT07167511 ·Status: COMPLETED
-
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
NCT07285096 ·Status: RECRUITING
-
Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children
NCT07086937 ·Status: COMPLETED ·Phase: NA
-
A Multi-center Study for Eradication of Refractory Helicobacter Pylori
NCT02741414 ·Status: UNKNOWN ·Phase: NA
-
High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)
NCT07121205 ·Status: COMPLETED
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses
NCT05431075 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin
NCT06351891 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose Administration
NCT03009760 ·Status: COMPLETED ·Phase: PHASE1
-
Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients
NCT03297242 ·Status: UNKNOWN
-
Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection
NCT05549115 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication
NCT07333001 ·Status: COMPLETED
-
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication
NCT06723197 ·Status: RECRUITING ·Phase: PHASE4